EVALUATION OF PSA ACCURACY FOR THE DETECTION OF PROSTATE CANCER IN OBESE MEN: RESULTS FROM A EUROPEAN BIOPSY COHORT

被引：0
|
作者：
Banez, L. [1 ,2 ]
De Nunzio, C. [3 ]
Trucchi, A.
Cantiani, A. [3 ]
Albisinni, S. [3 ]
Freedland, S. J. [1 ,2 ]
Tubaro, A. [3 ]
机构：
[1] Duke Univ, Div Urol Surg, Med Ctr, Dept Surg, Durham, NC 27706 USA
[2] Duke Univ, Duke Prostate Ctr, Med Ctr, Dept Surg, Durham, NC 27706 USA
[3] Univ Roma La Sapienza, St Andrea Hosp, Dept Urol, Rome, Italy
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2011年 / 10卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(11)60623-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：205 / 205
页数：1
相关论文
共 50 条
  • [41] Evaluation of prostate cancer risk in men with PSA < 1.5.
    Stanton, Whitney N.
    Crawford, E. David
    Arangua, Paul
    Hoenemeyer, John
    La Rosa, Francisco G.
    van Bokhoven, Adrie
    Lucia, M. Scott
    Poage, Wendy
    Werahera, Priya N.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06) : 64 - U3
  • [42] Prostate cancer detection rate at low PSA levels: Results from the Tyrol PSA-screening project
    Horninger, W
    Volgger, H
    Niescher, M
    Rogatsch, H
    Klocker, H
    Bartsch, G
    JOURNAL OF UROLOGY, 2002, 167 (04): : 324 - 325
  • [43] The clinical impact of the PSA assay who calibration on prostate biopsy rates and prostate cancer detection
    Jansen, Flip H.
    Roobol, Monique J.
    Bangma, Chris H.
    van Schaik, Ron H. N.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 602 - 603
  • [44] PSA Doubling Time as a Predictive Factor on Repeat Biopsy for Detection of Prostate Cancer
    Shimbo, Masashi
    Tomioka, Susumu
    Sasaki, Makoto
    Shima, Takayuki
    Suzuki, Noriyuki
    Murakami, Shino
    Nakatsu, Hiroomi
    Shimazaki, Jun
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (11) : 727 - 731
  • [45] MULTICENTER EVALUATION OF THE PROSTATE HEALTH INDEX (PHI) FOR DETECTION OF AGGRESSIVE PROSTATE CANCER IN BIOPSY-NAIVE MEN
    de la Calle, Claire
    Patil, Dattatraya
    Wei, John
    Scherr, Douglas
    Sokoll, Lori
    Chan, Daniel
    Siddiqui, Javed
    Mosquera, Juan Miguel
    Rubin, Mark
    Sanda, Martin
    JOURNAL OF UROLOGY, 2015, 193 (04): : E956 - E957
  • [46] Transperineal vs. transrectal MRI-targeted prostate biopsy: Evaluation of cancer detection risk and biopsy accuracy for clinical significant prostate cancer
    Zattoni, F.
    Marra, G.
    Kasivisvanathan, V.
    Kretschmer, A.
    Apfelbeck, M.
    Barletta, F.
    Cirulli, G.
    Marquis, A.
    Gontero, P.
    Guo, H.
    Zhuang, J.
    Morlacco, A.
    Soligo, M.
    Dal Moro, F.
    Gandaglia, G.
    EUROPEAN UROLOGY, 2021, 79 : S1348 - S1349
  • [47] No excess mortality after prostate biopsy: results from the European Randomized Study of Screening for Prostate Cancer
    Carlsson, Sigrid V.
    Holmberg, Erik
    Moss, Sue M.
    Roobol, Monique J.
    Schroder, Fritz H.
    Tammela, Teuvo L. J.
    Aus, Gunnar
    Auvinen, Anssi P.
    Hugosson, Jonas
    BJU INTERNATIONAL, 2011, 107 (12) : 1912 - 1917
  • [48] Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years
    Sun, Leon
    Moul, Judd W.
    Hotaling, James M.
    Rampersaud, Edward
    Dahm, Phillipp
    Robertson, Cary
    Fitzsimons, Nicholas
    Albala, David
    Polascik, Thomas J.
    BJU INTERNATIONAL, 2007, 99 (04) : 753 - 757
  • [49] VALUE OF PROSTATE SPECIFIC ANTIGEN (PSA) MASS RATIO IN THE DETECTION OF PROSTATE CANCER IN MEN WITH PSA ≤ 10 NG/ML
    Hong, Sung Kyu
    Oh, Jong Jin
    Lee, Sangchul
    Lee, Byung Ki
    Joo, Young Min
    Jeong, Chang Wook
    Jeong, Seong Jin
    Byun, Seok-Soo
    Lee, Sang Eun
    JOURNAL OF UROLOGY, 2012, 187 (04): : E895 - E895
  • [50] PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study
    Meunier, Matthias E.
    Neuzillet, Yann
    Dreyfus, Jean-Francois
    Schneider, Marc
    Roupret, Morgan
    Cathelineau, Xavier
    Raynaud, Jean-Pierre
    Lebret, Thierry
    Botto, Henry
    WORLD JOURNAL OF UROLOGY, 2021, 39 (08) : 2945 - 2951
12345